Nanovaccines in aquaculture, an alternative for disease management
DOI:
https://doi.org/10.30973/inventio/2020.16.40/7Keywords:
Nanovacunas, enfermedades, pecesAbstract
Among the aquaculture activity, which is among the most important in the world, there are factors that impede the expected development and cause losses of millions of dollars. One of these factors is vibriosis, one of the most infectious diseases and it has a great impact on this activity. The objective of this article is to expose the characteristics of this disease that damages fish in tropical and subtropical zones around the world, in addition to exposing all the existent vaccines to try to eradicate it. There are currently 26 vaccines in commercial use, but most are aimed at the Atlantic salmon and many other fish species have been left unprotected, in addition to the high costs of vaccine production. In spite of the existence of these antibiotics to treat vibriosis, improper use has resulted in the creation of more harmful strains.
References
Adams, A. (2019). Progress, challenges and opportunities in fish vaccine development. Fish and Shellfish Immunology, 90, 210-214. https://doi.org/10.1016/j.fsi.2019.04.066
Ma, J., J. Bruce, T., M. Jones, E. y D. Cain, K. A (2019). Review of Fish Vaccine Development Strategies: Conventional Methods and Modern Biotechnological Approaches. Microorganisms, 7 (11), 569. https://doi.org/10.3390/microorganisms7110569
Shaalan, M. Saleh, M., El-Mahdy, M. y El-Matbouli, M. (2016). Recent progress in applications of nanoparticles in fish medicine: A review. Nanomedicine: Nanotechnology, Biology and Medicine, 12 (3), 701-710. https://doi.org/10.1016/j.nano.2015.11.005
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Norma Hernández, Elizabeth Monreal-Escalante, Gabriela Navarro-Tovar, Carlos Angulo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Esta revista proporciona acceso abierto inmediato a su contenido, con base en el principio de ofrecer al público un acceso libre a las investigaciones para contribuir a un mayor intercambio global de conocimientos. Se distribuye bajo una licencia Creative Commons Reconocimiento-NoComercial 4.0 Internacional License.
